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Abstract
Introduction: Airway dysfunction in patients with the Acute Respiratory Distress Syndrome (ARDS) is evidenced by
expiratory flow limitation and dynamic hyperinflation. These functional alterations have been attributed to closure/
obstruction of small airways. Airway morphological changes have been reported in experimental models of acute
lung injury, characterized by epithelial necrosis and denudation in distal airways. To date, however, no study has
focused on the morphological airway changes in lungs from human subjects with ARDS. The aim of this study is
to evaluate structural and inflammatory changes in distal airways in ARDS patients.
Methods: We retrospectively studied autopsy lung tissue from subjects who died with ARDS and from control
subjects who died of non pulmonary causes. Using image analysis, we quantified the extension of epithelial
changes (normal, abnormal and denudated epithelium expressed as percentages of the total epithelium length),
bronchiolar inflammation, airway wall thickness, and extracellular matrix (ECM) protein content in distal airways. The
Student’s t-test or the Mann-Whitney test was used to compare data between the ARDS and control groups.
Bonferroni adjustments were used for multiple tests. The association between morphological and clinical data was
analyzed by Pearson rank test.
Results: Thirty-one ARDS patients (A: PaO2/FiO2 ≤200, 45 ± 14 years, 16 males) and 11 controls (C: 52 ± 16 years, 7
males) were included in the study. ARDS airways showed a shorter extension of normal epithelium (A:32.9 ± 27.2%,
C:76.7 ± 32.7%, P < 0.001), a larger extension of epithelium denudation (A:52.6 ± 35.2%, C:21.8 ± 32.1%, P < 0.01),
increased airway inflammation (A:1(3), C:0(1), P = 0.03), higher airway wall thickness (A:138.7 ± 54.3 μm, C:86.4 ±
33.3 μm, P < 0.01), and higher airway content of collagen I, fibronectin, versican and matrix metalloproteinase-9
(MMP-9) compared to controls (P ≤0.03). The extension of normal epithelium showed a positive correlation with
PaO2/FiO2 (r
2 = 0.34; P = 0.02) and a negative correlation with plateau pressure (r
2 = 0.27; P = 0.04). The extension
of denuded epithelium showed a negative correlation with PaO2/FiO2 (r
2 = 0.27; P = 0.04).
Conclusions: Structural changes in small airways of patients with ARDS were characterized by epithelial
denudation, inflammation and airway wall thickening with ECM remodeling. These changes are likely to contribute
to functional airway changes in patients with ARDS.
Introduction
Acute Respiratory Distress Syndrome (ARDS) is charac-
terized by inflammation-mediated alveolar/capillary
barrier dysfunction with interstitial and airspace protein-
rich edema fluid, resulting in ventilation-perfusion
mismatch and consequent severe hypoxemia [1]. Several
ventilatory strategies are implemented in these patients
to restore adequate oxygenation; however, mechanical
ventilation itself can increase damage to the lung tissue
[2]. The inflammatory changes, the loss of airspace
capacity secondary to lung collapse and the dynamic
reopening of distal lung units during mechanical ventila-
tion, result in a marked decrease in lung compliance.
Furthermore, an increase in lung resistance has also
been reported, which was partially attributed to
impaired peripheral airway function [3]. Studies that
report expiratory flow limitation and dynamic
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these functional alterations are related to airway closure
[4-7]. Recent studies suggest a role for distal airway
epithelium injury in the pathophysiology of human
acute lung injury (ALI) and propose that Clara cell
CC16 protein levels in plasma and pulmonary edema
fluid can be used as a biomarker for the diagnosis of
ALI/ARDS [8].
Several experimental models have been proposed to
reproduce the functional and morphological lung
changes in ARDS. Models of ventilation-induced lung
injury have shown that ventilation of normal or lavaged
lungs with low end-expiratory lung volume causes a per-
sistent increase in airway resistance and histological evi-
dence of peripheral airwayi n j u r yc h a r a c t e r i z e db y
bronchiolar epithelial necrosis and sloughing and rup-
ture of alveolar-bronchiolar attachments [9-13]. These
morphological and functional alterations have been
mainly attributed to shear stresses caused by cyclic
opening and closing of peripheral airways [3,7].
Since airway mechanics is largely dependent on airway
structure, extracellular matrix (ECM) composition and
distribution, in addition to airway-parenchyma interde-
pendence forces, the functional airway alterations
observed in ARDS patients are likely associated with air-
way morphological changes [14]. Although both human
and experimental studies have suggested that airway
changes contribute to impaired lung function in acute
lung injury, no study to date has focused on distal air-
way morphological changes in the lungs of human sub-
jects with ARDS. Therefore, the aim of the present
study was to analyze the structural and inflammatory
changes in small airways of patients with ARDS. For
this purpose, we measured the extent of epithelial
alterations, airway dimensions and the expression of
major lung ECM elements and their regulators within
the small airway walls of patients with ARDS submitted
to autopsy and compared them with control subjects.
We further correlated the airway changes to clinical
data and mechanical ventilation parameters.
Materials and methods
This is a retrospective study using archived material
from routine autopsies performed at the Autopsy Ser-
vice of Sao Paulo University Medical School. The study
was approved by the institutional review board for
human studies (CAPPesq-FMUSP). Consent for per-
forming autopsy was obtained from the next of kin of
all the subjects involved in the study.
Study population
Thirty-one patients with ARDS submitted to autopsy
between 2004 and 2007 were retrospectively included in
the study. Inclusion criteria were clinical diagnosis of
ARDS [15], histological findings of diffuse alveolar
damage [16], an absence of chronic lung diseases, and
sufficient archived autopsy material (at least three small
airways per patient) for analyses. ARDS was defined as
the 1994 American-European Consensus criteria [15],
that is, acute onset, the ratio of arterial oxygen tension
to the fraction of inspired oxygen (PaO2/FiO2) ≤200,
bilateral infiltrates on chest radiograph and no left atrial
hypertension. Twenty-three non-smoker patients who
died of non-pulmonary causes, without previous lung
diseases were selected for controls. From these, 12 were
excluded due to histological lung alterations (bronchop-
neumonia, pulmonary edema, and pulmonary hemor-
rhage) and 11 patients with normal lung histology were
used as controls. The following clinical data were
assessed in medical charts: age, gender, predisposing
cause of ARDS, days of ARDS evolution (time interval
between ARDS diagnosis and death), and values of
PaO2, plateau pressure, positive end-expiratory pressure
(PEEP), driving pressure and PaO2/FiO2.
Tissue processing
Paraffin blocks of lung tissue collected during autopsy
were retrieved from the archives of the Department of
Pathology of Sao Paulo University Medical School. In
the routine autopsies, three to four fragments of lung
tissue were collected from any regions of altered lung
parenchyma. In normal lungs, one fragment of lung tis-
sue was collected from each lobe. The tissue had been
previously fixed in 10% buffered formalin for 24 hours,
routinely processed and paraffin embedded. Five μm-
thick sections were stained with hematoxylin and eosin
(H&E) and with Weigert’s Resorcin-Fuchsin staining for
elastic fibers [17]. The following proteins were identified
with immunohistochemistry (IHC) as previously
described [18]: collagens type I (COLI) and type III
(COLIII), fibronectin, versican and matrix metalloprotei-
nases (MMP) -2 and -9. Antibody types and pre-treat-
ments used are shown in Table 1.
Morphological analysis
Only transversely cut small airways were analyzed,
defined as those showing a short/long diameter ratio
greater than 0.6 [19]. Small airways were defined based
on their epithelial basement membrane (BM) perimeter
(BM perimeter ≤6 mm) [19,20]. Airways were subdi-
vided into epithelial layer, inner layer (located between
the epithelium and the internal smooth muscle border),
smooth muscle (SM), and outer layer (located between
the external SM border and the alveolar parenchyma)
(Figure 1) [19]. In each airway, the entire circumference
was analyzed at a 400× magnification by an investigator
blinded to the study group. Measurements were taken
using image analysis with the software Image-Pro
® Plus
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® (Media Cybernetics-Silver Spring,
MD, USA) on a personal computer connected to a digi-
t a lc a m e r ac o u p l e dt oam i c r o s c o p e( L e i c aD M R ,L e i c a
Microsystems Wetzlar GmbH, Wetzlar, Germany).
The following parameters were analyzed on H&E
stained slides: 1) the extent of normal epithelium,
abnormal epithelium (epithelial cells with histological
signs of necrosis and/or degeneration) and denudated
epithelium (BM exposed) expressed as a percent of the
total epithelium length; 2) thickness of the inner, SM
and outer airway layers and the total airway wall
expressed as layer area corrected by the corresponding
BM perimeter (μm
2/μm); and 3) inflammation index
determined semiquantitatively based on the presence of
inflammatory cells infiltrating the airway wall, using a
four-grade scale: absent = 0, minimal inflammation = 1,
moderate inflammation = 2 and marked inflamma-
tion = 3 [13].
The content of ECM proteins and MMPs was deter-
mined in IHC-stained slides. The area of ECM proteins
positive staining was determined in three airway regions:
inner, SM and outer layers. The area of MMP-positive
staining was determined in two airway regions: epithelial
layer and total airway wall (including the inner and
outer layers and SM together). Protein content was
expressed as positive area divided by airway BM length
(μm
2/μm).
Clinical-morphological correlations
Since lung injury can be observed after a few hours of
mechanical ventilation [12], we investigated the possible
association of morphological airway changes with
mechanical ventilation and disease severity in ARDS
patients who died within 48 hours after the diagnosis
(n = 16). For this purpose we correlated the morpholo-
gical parameters with ventilatory parameters (mean
values of plateau pressure, driving pressure and PEEP)
and PaO2/FiO2 value obtained at the moment of the
clinical diagnosis.
Statistical analysis
Data are presented as mean ± SD or median (interquar-
tile range). After testing for distribution of data, the Stu-
dent’s t-test or the Mann-Whitney test were used to
Table 1 Antibodies and processing used in immunohistochemical analyses
Antibody Pre-treatment Specie Clone Dilution Origin
Collagen I Citrate Goat Polyclonal 1:1000 US Biological-Swampscott, Massachusetts/USA
Collagen III Trypsin Mouse III-53 1:100 Oncogene & Calbiochem, Darmstadt/Germany
Fibronectin Citrate Rabbit Polyclonal 1:6000 Dako, Glostrup/Denmark
Versican Trypsin Mouse 2-B-1 1:100 Seikagaku CO, Tokyo/Japan
MMP-2 Citrate Mouse A-Gel VC2 1:3000 LabVision, Fremont/USA
MMP-9 Citrate Mouse 56-2A4 1:50 Calbiochem, Darmstadt/Germany
MMP, matrix metalloproteinase.
Figure 1 A schematic representation of image analysis. (A) Small airway stained with H&E. (B) The same airway subdivided into epithelium
(EP), inner layer (IL), smooth muscle (SM), and outer layer (OL). L = lumen. The green line represents the basement membrane.
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Bonferroni adjustments were used for multiple tests.
The association between morphological and clinical data
was analyzed by Pearson rank test. Statistical analysis
was performed using the statistical package SPSS 15.0
(SPSS, Chicago, IL, USA). The level of significance was
set at P < 0.05.
Results
Study population
Demographic and clinical data of ARDS patients
(n = 31) and controls (n = 11) are presented in Table 2.
The mean ± SD age of ARDS patients and controls was
45 ± 14 and 52 ± 16 years, respectively (P =0 . 1 8 ) .T h e
main predisposing factors for ARDS were pneumonia
(42%) and sepsis (35%). Pulmonary ARDS (ARDSp) and
extrapulmonary ARDS (ARDSext) accounted for 52%
(n =1 6 )a n d4 8 %( n =1 5 )o ft h ep a t i e n t s, respectively.
These two subgroups were also similar with respect to
age (ARDSp = 45.9 ± 13.6 years and ARDSext = 43.6 ±
4.3) and gender (ARDSp = 7 F/9 M and ARDSext = 8
F/7 M). Days of ARDS evolution (time interval between
ARDS diagnosis and death) ranged from 1 to 24; how-
ever, most patients (71%) died in the first week, and
52%, within the first 48 hours (Table 3). Ventilatory
parameters and PaO2/FiO2 values of ARDS patients are
presented in Table 3. Median values of plateau pressure,
PEEP and driving pressure were 28(10) cmH2O, 11(8)
cmH2O and 15(5) cmH2O, respectively. All patients
were ventilated using a lung-protective strategy with a
low tidal volume (≤6 mL/Kg). Control patients did not
receive mechanical ventilation. One control subject died
at home, seven controls arrived at the emergency room
in cardiorespiratory arrest and three controls were
admitted to the hospital for non-pulmonary conditions.
All control patients were submitted to resuscitation
maneuvers for a maximum of one hour. All control
patients were non-smokers.
Morphological analysis
All available transversely cut small airways for each
patient were analyzed, varying from three to six airways
per patient (mean of 3.6 per patient in each staining).
A total of 1,218 airways were analyzed considering all
the stainings used. The median perimeter of small air-
ways for ARDS patients and controls was 1.94(1.13) mm
and 2.06(1.21) mm, respectively, corresponding to small
membranous bronchioles [21]. There was no significant
difference in airway perimeter between ARDS patients
and controls.
Structural and inflammato r yd a t aa r ep r e s e n t e di n
T a b l e4a n dF i g u r e2 .T h e r ew a sas i g n i f i c a n t l yl o w e r
extent of normal epithelium (P < 0.001) and a higher
extent of abnormal epithelium (P = 0.007) and epithelial
denudation (P = 0.015) in the ARDS group compared to
controls. The ARDS group showed a significantly higher
thickness of the total airway wall, inner layer and outer
layer compared to controls (P ≤0.03). The inflammation
index was also higher in ARDS patients than in controls
(P = 0.03).
Immunoreactivity of ECM components and MMPs
showed similar patterns of distribution in the lung tissue
of both ARDS patients and controls. MMPs showed
positive staining mainly in inflammatory cells (mostly
monocytes/macrophages and PMNs) and weak
Table 2 Clinical data of Acute Respiratory Distress
Syndrome (ARDS) patients and controls
Characteristics ARDS Controls
Number 31 11
Age (years)
a 44 (20) 48 (25)
Gender (M/F) 16/15 7/4
Predisposing factor for ARDS, n (%) NA
Pneumonia 13 (42)
Sepsis 11 (35)
Aspiration 2 (6)
Pancreatitis 2 (6)
Hypovolemic shock 2 (6)
Alveolar bleeding 1 (3)
Co-morbidities, n (%)
Systemic arterial hypertension 9 (20) 6 (54)
Chronic hepatopathy 9 (20) 1 (9)
AIDS 8 (17) –
Diabetes mellitus 5 (11) 3 (27)
Systemic Lupus Erythematosus 3 (6.5) –
Pneumocystosis 3 (6.5) –
Pulmonary hypertension 1 (2.2) –
Multiple sclerosis 1 (2.2) –
Multiple myeloma 1 (2.2) –
Crohn disease 1 (2.2) –
Chagas disease 1 (2.2) 1 (9)
Schistosomosis 1 (2.2) –
Acute myeloid leukemia 1 (2.2) –
Lymphoma 1 (2.2) –
Tuberculosis 1 (2.2) –
Epilepsy – 1 (9)
Primary Cause of Death, n (%)
Multiorgan failure 14 (45)
Refractory sepsis 7 (23)
Respiratory failure 4 (13)
Thoracic bleeding 2 (6)
Gastrointestinal bleeding 4 (13) 1 (9)
Cardiovascular diseases 9 (82)
Vesical bleeding 1 (9)
Total length hospitalization, days 15 (19) 0 (0.08)
Data are given as median (interquartile range) or n (percentage).
M, masculine; F, feminine; AIDS, acquired Immunodeficiency Syndrome; NA,
non applicable.
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sentative photomicrographs of airway ECM and MMP-9
expression are shown in Figure 3. Figure 4 shows pro-
tein content in ARDS patients and controls. We
observed higher content of COL I, fibronectin and versi-
can in the outer airway layer of ARDS patients com-
pared to controls (P ≤ 0.03). Versican expression was
also higher in the inner airway layer in ARDS patients
(P < 0.02). There were no differences in COL III and
elastic fiber content between the two groups, and no dif-
ference in the content of ECM proteins within the SM
layer. We observed increased expression of MMP-9 in
the ARDS group only in the airway wall (P = 0.003),
with no differences observed within the epithelial layer.
There were no differences in MMP-2 expression
between the two groups.
Comparisons between ARDSp and ARDSext sub-
groups showed higher levels of MMP-9 in the airways
from the ARDSp group (P = 0.03). There were no signif-
icant differences in the inflammation index or in any
structural parameter between the two subgroups. To
evaluate the airway inflammation and structural changes
over the course of the disease, we also categorized our
ARDS patients into two subgroups according to time
Table 3 Days of evolution, ventilatory parameters and PaO2/FiO2 values of Acute Respiratory Distress Syndrome
(ARDS) patients
Patient Days of ARDS Plateau pressure
a PEEP
a Driving pressure
a PaO2/FiO2
1 1 18 08 10 161.0
2 1 35 20 15 93.2
3 1 12 06 06 170.7
4 1 28 14 12 82.0
5 1 21 9 12 93.7
6 1 25 10 15 68.1
7 1 30 08 22 79.5
8 1 40 10 30 47.2
9 1 40 15 25 51.0
10 2 25 10 15 166.3
11 2 32 22 10 137.3
12 2 35 17 18 104.2
13 2 28 13 15 133.5
14 2 23 08 15 130.8
15 2 27 14 13 156.5
16 2 21 11 10 111.7
17 3 38 18 20 84.0
18 3 30 14 16 166.2
19 4 25 11 14 197.0
20 6 21 09 12 149.7
21 6 25 10 15 196.7
22 7 21 07 14 189.7
23 8 28 11 17 126.3
24 9 29 17 12 119.7
25 10 30 14 16 108.3
26 13 22 09 13 153.2
27 14 28 17 11 195.6
28 16 20 10 10 186.7
29 19 39 18 21 199.0
30 22 25 14 11 182.4
31 24 37 20 17 173.7
Median (IQR) 2 (8) 28 (10) 11 (8) 15 (5) 137 (80)
PaO2/FiO2, ratio of arterial oxygen tension to the fraction of inspired oxygen.
PEEP, positive end-expiratory pressure.
For each patient, plateau pressure and PEEP correspond to mean values in the first 48 hours.
PaO2/FiO2 correspond to values assessed at the time of clinical diagnosis.
a cmH2O.
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Ards1 = 1 to 6 days (21 patients) and Ards2 = ≥7d a y s
(11 patients). We did not find any significant differences
in inflammatory or structural parameters between the
two subgroups.
Clinical-morphological correlations
The extension of normal epithelium showed a significant
positive correlation with PaO2/FiO2 (r
2 = 0.34; P = 0.018)
and a negative correlation with plateau pressure
(r
2 =0 . 2 7 ;P = 0.039) (Figure 5). In addition, the exten-
sion of denuded epithelium showed a negative correla-
tion with PaO2/FiO2 (r
2 =0 . 2 7 ;P = 0.038). There was no
correlation between values of PEEP or driving pressure
and the morphological parameters.
Table 4 Structural and inflammatory data on small
airways in ARDS patients and controls
ARDS Controls P
Normal epithelium 32.9 ± 27.2 76.7 ± 32.7 < 0.001
Abnormal epithelium 14.4 ± 14.8 1.37 ± 3.20 0.007
Denudated epithelium 52.6 ± 35.2 21.8 ± 32.1 0.015
Airway wall thickness 138.7 ± 54.3 86.4 ± 33.3 0.005
Inner layer thickness 35.2 ± 32.0 17.2 ± 8.14 0.034
Smooth Muscle thickness 14.8 ± 8.20 18.5 ± 22.7 0.427
Outer layer thickness 88.7 ± 29.9 50.4 ± 17.7 < 0.001
Inflammation index [median(range)] 1(3) 0(1) 0.027
ARDS, acute respiratory distress syndrome.
Values are expressed as mean ± SD, unless otherwise specified. Epithelium
parameters are expressed as a percentage of the airway basement membrane
perimeter (%). Airway layers are presented as area (μm
2) corrected by the
basement membrane perimeter (μm).
Figure 2 Lung histology from ARDS and control patients. Representative photomicrographs of distal airway and alveolar tissue from ARDS
(A and C) and control (B and D) patients. ARDS lungs show extensive intra-alveolar exudate (A) and small airway thickening with mild
inflammation and epithelium denudation (C). SA = airway; L = lumen; EP = epithelium; SM = smooth muscle; OL = outer layer; IL = inner layer.
H&E staining. Scale bars: A and B = 100 μm, C and D = 50 μm.
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Page 6 of 12Figure 3 Representative photomicrographs of extracellular matrix proteins and matrix metalloproteinase-9 expression in the
airways. Photomicrographs of small airways from ARDS patients (A, C, E, G) and controls (B, D, F, H) stained with anti-collagen I (A and B),
anti-fibronectin (C and D), anti-versican (E and F) and anti-MMP-9 (G and H). ARDS airways show higher content of collagen I, fibronectin
and versican and higher MMP-9 expression by inflammatory cells. L = lumen; SM = smooth muscle; OL = outer layer; IL = inner layer.
Scale bars = 50 μm.
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In the present study, we analyzed for the first time the
structural changes in small airways in patients with
ARDS compared to control subjects. Our main findings
were the presence of epithelial denudation, airway
inflammation and increased thickness of small airway
walls with deposition of collagen I, fibronectin and versi-
can, mainly localized to the outer wall.
Recent studies have suggested that the peripheral air-
ways play an important role in the pathophysiology of
ALI/ARDS [3]; however, no study has focused on airway
morphological changes in lungs from human subjects
Figure 4 Protein content in ARDS patients and controls. The graphs show collagen I, fibronectin, versican and MMP-9 content (μm
2/μm) in
the small airways of ARDS patients and controls. IL = inner layer, OL = outer layer. Bars represent mean; lines represent SD. *P ≤ 0.03 compared
with controls; †P < 0.003 compared with controls.
Figure 5 Clinical-morphological correlations in ARDS patients. The graphs show the correlation (Pearson test) between epithelial
morphological changes and PaO2/FiO2 (A) and plateau pressure (B) in patients who died within 48 hours after the clinical diagnosis (n = 16).
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investigate these changes and have shown epithelial
necrosis and denudation in distal airways of animals
ventilated with low lung volumes [9-12]. Our results are
in line with these experimental studies and show that
bronchiolar epithelium denudation is also present in
humans and is associated with ARDS severity. The
mechanisms of epithelial injury and denudation are not
completely understood but are likely to result from
changes in shear stress due to reopening of either col-
lapsed small airways or non-collapsed flooded airways
[ 7 , 2 2 ]a n df r o ms t r e t c h - i n d u c e dh y p e r d i s t e n s i o no f
epithelial cells [23]. Gadigliali and Gaver (2008) sug-
gested that this increased stress on the airway epithelial
cell lining may induce significant cellular deformations,
cell death, and/or disruption of cell adhesions. The
damaged epithelial cell may in turn upregulate inflam-
matory pathways and/or alter surfactant secretion [24].
Airway inflammation is diffusely present in surfactant-
depleted lungs of rabbits submitted to low end-expira-
tory lung volume ventilation [13] and in rats submitted
to high volume-induced lung injury [23]. Our results
show that distal airway inflammation is also present in
human ARDS lungs. Whether airway inflammation in
ARDS represents a response of terminal bronchioles to
the primary insult or is rather a spreading of inflamma-
tory cells from the alveolar tissue is not clear. In either
case we suggest that airway inflammation is likely to be
involved in the pathogenesis of airway remodeling in
ARDS.
Previous studies evaluating ECM changes in ARDS
have shown altered alveolar septa with lung fibrosis
[25] and increased alveolar content of collagen and
elastic fibers [26-28], fibronectin [29] and versican
[30] in exudative and/or proliferative phases of lung
injury. The fibroproliferative process characterized by
collagen deposition, even in the early phase of ARDS,
is associated with a severe reduction in respiratory
system compliance [31]. We show for the first time
that remodeling is also present at the terminal
bronchiolar level and suggest that these structural air-
way changes may also have functional implications.
The functional consequences of airway remodeling are
dependent on which layer in the airway wall is chan-
ged as well as on the composition and mechanical
properties of the material that is altered [32]. The
i n n e ra r e ap r o v i d e sr e s i s t a n c eo ft h et i s s u et oc o m -
pression; the smooth muscle layer is usually altered in
pulmonary diseases characterized by bronchoconstric-
tion; and the outer wall is directly attached to the
lung parenchyma and is, therefore, crucial for the
maintenance of lung tissue structure and transmission
of elastic forces. Thus, we believe that airway com-
partmentalization provides important insight toward a
better understanding of structure-function relation-
ships in pulmonary diseases. Airway dysfunction in
patients with ARDS who are ventilated with low PEEP
is characterized by expiratory flow limitation and gas
trapping [4,5], which have been related to airway clo-
sure and inhomogeneous distribution of ventilation
[6,7]. The mechanisms involved in airway closure
include surfactant dysfunction and a decrease in air-
way-parenchyma interdependence secondary to inter-
stitial edema, alveolar collapse, and possibly the
rupture of alveolar attachments [3,11,12]. Since the
outer airway layer is the main region where mechani-
cal forces are transmitted from the alveolar parench-
yma to the airway wall, it represents a critical site that
may be affected by both the inflammatory process and
the mechanical damage caused by abnormal stress.
Interestingly, in this study collagen I, fibronectin and
versican levels were primarily increased in the outer
airway wall, which could contribute to airway-par-
enchyma uncoupling by altering the mechanical inter-
dependence between these two compartments.
The higher MMP-9 expression seen in the ARDS
group is in accordance with previous studies showing
increased levels of MMP-9 in the bronchoalveolar lavage
of patients with ARDS [33,34]. The observation of
increased MMP-9 expression in inflammatory cells
w i t h i nt h ea i r w a yw a l ls u g g e s t st h a tM M P - 9m a yb e
involved in airway ECM remodeling in ARDS patients.
Increased MMP-9 expression could either be associated
with higher ECM turnover within the airway wall or
represent a response to excessive matrix deposition in
an attempt to restore equilibrium to the ECM
composition.
In chronic airway inflammatory lung diseases, airway
remodeling is correlated with marked changes in airway
mechanics and symptoms related to airway obstruction
[14]. Although airway obstruction is not a characteristic
of ALI, patients who survive ARDS can present mild to
moderate abnormalities in lung function evidenced by
decreased FEV1, FVC and/or FEV1/FVC evaluated one
to three years after hospital discharge [35-37]. It is pos-
sible that the persistence of these pulmonary function
changes is related to airway remodeling.
To determine if the airway changes were different in
patients with distinct predisposing factors, ARDS
patients were divided into pulmonary and extrapulmon-
ary subgroups. Although we observed higher levels of
MMP-9 in the airways from the ARDSp subgroup, there
were no differences in the inflammation index or in any
structural parameter between the ARDSp and ARDSext
subgroups. These findings suggest that the airway altera-
tions in ARDS were the result of the inflammatory
insult (and/or ventilator injury), independent of the pri-
mary cause. We also categorized our ARDS patients
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ARDS diagnosis and death. We did not find any signifi-
cant differences in inflammatory or structural para-
meters between patients who died in the first week and
patients who died more than seven days after diagnosis,
suggesting that the airway alterations were present at
the start of the syndrome and were maintained over
time.
Pulmonary injury is heterogeneously distributed in
ARDS, resulting in inhomogeneous ventilation and
predisposing the lung to ventilator-induced lung injury
[2]. Previous studies suggest that lung injury in ALI is
more severe in the atelectatic dependent lung regions
[38,39]; however, more recent studies have suggested
that the peripheral airway injury observed in experi-
mental ALI is diffusely distributed in both dependent
and non-dependent regions [13]. One limitation of our
study was the retrospective analysis of lung tissue,
which did not allow us to systematically assess regional
differences in airway injury in these lungs from human
subjects with ARDS. Due to the retrospective character
of the study, another limitation was the lack of sys-
tematic recording of clinical data. In many charts,
information regarding smoking habits or the specifics
of the lung mechanics was not available, which could
have influenced the interpretation of our results.
F u r t h e r m o r e ,s i n c ew eo n l ya n a l y z e dt i s s u ef r o m
patients who died, the extent to which the results
obtained in the present study can be transposed to the
less severe cases of ARDS is unclear.
Although the observed airway changes are likely to
play a role in the pathogenic mechanisms of ALI, it is
not clear if these changes are due to the insult leading
to ARDS or to ventilator injury. It is well known that
pulmonary injury in ARDS patients can be exacer-
bated by the ventilatory strategy [2], as indicated by
clinical trials showing significantly higher mortality
among patients who received ventilation with high
tidal volume and high inspiratory plateau pressures
[40-42]. In our patients, airway epithelial injury
showed significant correlations with PaO2/FiO2 and
inspiratory pressure values, suggesting that both the
primary pulmonary insult leading to ARDS and the
ventilator injury are associated with airway structural
alterations in ARDS patients. Rouby et al. [43] ana-
lyzed the histological aspects of pulmonary baro-
trauma in critically ill patients with acute respiratory
failure and observed in 6 out of 30 lungs severe
damage to terminal bronchioles characterized by
bronchiolar dilation, epithelial hyperplasia and meta-
plasia. Similarly to our results, the authors suggested
that mechanical ventilation with a high peak airway
pressure plays a role in the pathogenesis of bronchial
injury and airspace enlargement.
Conclusions
Our results revealed structural changes in the small air-
ways of patients with ARDS, characterized by epithelial
denudation, inflammation and airway wall thickening
with ECM remodeling. These small airway alterations
a r el i k e l yt oc o n t r i b u t et oi m p a i r e dl u n gf u n c t i o ni n
patients with ARDS.
Key messages
￿ Patients with ARDS show evidence of airway dys-
function characterized by expiratory flow limitation
and dynamic hyperinflation. These functional altera-
tions have been attributed to closure/obstruction of
small airways. Airway morphological changes have
been reported in experimental models of acute lung
injury, characterized by epithelial necrosis and denu-
dation in distal airways.
￿ In the present study, we analyzed for the first time
the structural changes in distal airways in ARDS
patients, which were characterized by epithelial
denudation, inflammation and airway wall thickening
with extracellular matrix remodeling.
￿ These small airway alterations are likely to contri-
bute to impaired lung function in patients with
ARDS.
Abbreviations
ALI: acute lung injury; ARDS: acute respiratory distress syndrome; BM:
basement membrane; COLI: collagen type I; COLIII: collagen type III; ECM:
extracellular matrix; H&E: hematoxylin and eosin; IHC: immunohistochemistry;
MMP: matrix metalloproteinases; PaO2/FiO2: ratio of arterial oxygen tension
to the fraction of inspired oxygen; PEEP: positive end-expiratory pressure;
SM: smooth muscle.
Acknowledgements
MMBM received a fellowship from Fundação de Amparo à Pesquisa do
Estado de São Paulo (FAPESP). PHNS, TM, MBPA and MD receive individual
research grants from Conselho Nacional de Desenvolvimento Científico e
Tecnológico (CNPq). The study was supported by Laboratório de
Investigação Médica-LIM05 do Hospital das Clinicas da Faculdade de
Medicina da Universidade de São Paulo (LIMHC-FMUSP).
Author details
1Department of Pathology, Experimental Air Pollution Laboratory-LIM05, Sao
Paulo University Medical School, Av Dr. Arnaldo, 455, São Paulo, 01246-903,
Brazil.
2Pulmonary Division, Heart Institute (InCor), Sao Paulo University
Medical School, Av Dr Enéas Carvalho de Aguiar, 44, São Paulo, 05403-904,
Brazil.
Authors’ contributions
MMBM participated in the design of the study, carried out the
immunohistochemistry reactions and the morphometric analyses, performed
the statistical analysis and drafted the manuscript. RCPN and NI helped to
carry out the morphometric analyses and were involved in drafting the
manuscript. TL helped to carry out the morphometric analyses, was involved
in the acquisition of clinical data and was involved in revising the
manuscript. LFFS participated in the design of the study, performed the
histological analysis and the immunohistochemistry quality control, helped
at the statistical analysis and was involved in drafting the manuscript. PHNS
and TM contributed to the conception and design of the study and were
involved in drafting the manuscript. CRRC and MBPA contributed to the
conception and design of the study, contributed to analysis and
Morales et al. Critical Care 2011, 15:R4
http://ccforum.com/content/15/1/R4
Page 10 of 12interpretation of data and were involved in revising the manuscript. MD
conceived the study, performed the histological analysis, performed the
immunohistochemistry quality control, performed the statistical analysis,
drafted and revised the manuscript. All authors read and approved the final
version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 18 May 2010 Revised: 13 September 2010
Accepted: 6 January 2011 Published: 6 January 2011
References
1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J
Med 2000, 342:1334-1349.
2. Tremblay NL, Slutsky AS: Ventilator-induced lung injury: from the bench
to the bedside. Intensive Care Med 2006, 32:24-33.
3. Jain M, Sznajder JI: Peripheral airways injury in acute lung injury/acute
respiratory distress syndrome. Current Opinion in Critical Care 2008,
14:37-43.
4. Koutsoukou A, Armaganidis A, Stavrakaki-Kallergi C, Vassilakopoulos T,
Lymberis A, Roussos C, Milic-Emili J: Expiratory flow limitation and intrinsic
positive end-expiratory pressure at zero positive end expiratory pressure
in patients with adult respiratory distress syndrome. Am J Respir Crit Care
Med 2000, 161:1590-1596.
5. Kondili E, Prinianakis G, Athanasakis H, Georgopoulos D: Lung emptying in
patients with acute respiratory distress syndrome: effects of positive end
expiratory pressure. Eur Respir J 2002, 19:811-819.
6. Rylander C, Tylén U, Rossi-Norrlund R, Herrmann P, Quintel M, Bake B:
Uneven distribution of ventilation in acute respiratory distress
syndrome. Critical Care 2005, 9:R165-R171.
7. Milic-Emili J, Torchio R, D’Angelo E: Closing volume: a reappraisal (1967-
2007). Eur J Appl Physiol 2007, 99:567-583.
8. Kropski JA, Fremont RD, Calfee CS, Ware LB: Clara cell protein (CC16), a
marker of lung epithelial injury, is decreased in plasma and pulmonary
edema fluid from patients with acute lung injury. Chest 2009,
135:1440-1447.
9. Muscedere JG, Mullen JBM, Gan K, Slutsky AS: Tidal ventilation at low
airway pressures can augment lung injury. Am J Respir Crit Care Med
1994, 149:1327-1334.
10. D’Angelo E, Pecchiari M, Baraggia P, Saetta M, Balestro E, Milic-Emili J: Low-
volume ventilation causes peripheral airway injury and increased airway
resistance in normal rabbits. J Appl Physiol 2002, 92:949-956.
11. D’Angelo E, Pecchiari M, Gentile G: Dependence of lung injury on surface
tension during low-volume ventilation in normal open-chest rabbits. J
Appl Physiol 2007, 102:174-182.
12. D’Angelo E, Koutsoukou A, Della Valle P, Gentile G, Pecchiari M: Cytokine
release, small airway injury, and parenchymal damage during
mechanical ventilation in normal open-chest rats. J Appl Physiol 2008,
104:41-49.
13. Tsuchida S, Engelberts D, Peltekova V, Hopkins N, Frndova H, Babyn P,
McKerlie C, Post M, McLoughlin P, Kavanagh BP: Atelectasis Causes
Alveolar Injury in Nonatelectatic Lung Regions. Am J Respir Crit Care Med
2006, 174:279-289.
14. James A, Wenzel S: Clinical relevance of airway remodelling in airway
diseases. Eur Respir J 2007, 30:134-155.
15. Bernard GR, Artigas A, Bringhan KL, Carlet J, Falke K, Hudson L, Lamy M,
Legall JR, Morris A, Spragg R: The American-European Consensus
Conference on ARDS: definition, mechanisms, relevant outcomes, and
clinical coordination. Am J Resp Crit Care Med 1994, 149:818-824.
16. In Katzenstein and Askin’s Surgical Pathology of Non-Neoplastic Lung Disease.
Volume 13 in Major Problems in Pathology. Edited by: Katzenstein A-LA.
Philadelphia: Saunders; 2006:.
17. Weigert C: Über eine methode zur farbung elastischer fasern. Zentralbl
Allg Pathol Anat 1898, 9:289-292.
18. Araujo BB, Dolhnikoff M, Silva FFL, Elliot J, Lindeman JHN, Ferreira DS,
Mulder A, Gomes HAP, Fernezlian SM, James A, Mauad T: Extracellular
matrix components and regulators within the airway smooth muscle in
asthma. Eur Respir J 2008, 32:61-69.
19. Matsushita MM, Silva LFF, Santos MA, Fernezlian S, Schrumpf JÁ,
Roughley P, Hiemstra OS, Saldiva PHN, Mauad T, Dolhnikoff M: Airway
proteoglycans are differentially altered in fatal asthma. J Pathol 2005,
207:102-110.
20. Mauad T, Silva LF, Santos MA, Grinberg L, Bernardi FD, Martins MA,
Saldiva PH, Dolhnikoff M: Abnormal alveolar attachments with decreased
elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care
Med 2004, 170:857-862.
21. Carroll N, Elliot J, Morton A, James A: The structure of large and small
airway in nonfatal and fatal asthma. Am Rev Respir Dis 1993, 147:405-410.
22. Ghadiali SN, Gaver DP: Biomechanics of liquid-epithelium interactions in
pulmonary airways. Respir Physiol Neurobiol 2008, 163:232-243.
23. Copland IB, Kavanagh BP, Engelberts D, McKerlie C, Belik J, Post M: Early
changes in lung gene expression due to high tidal volume. Am J Respir
Crit Care Med 2003, 168:1051-1059.
24. Ghadiali SN, Gaver DP: An investigation of pulmonary surfactant
physicochemical behavior under airway reopening conditions. J Appl
Physiol 2000, 88:493-506.
25. Martin C, Papazian L, Payan MJ, Saux P, Gouin F: Pulmonary fibrosis
correlates with outcome in adult respiratory distress syndrome. A study
in mechanically ventilated patients. Chest 1995, 107:196-200.
26. Liebler JM, Qu Z, Buckner B, Powers MR, Rosenbaum JT: Fibroproliferation
and mast cells in the acute respiratory distress syndrome. Thorax 1998,
53:823-829.
27. Krein PM, Sabatini PJB, Tinmouth W, Green FHY, Winston BW: Localization
of insulin-like growth factor-i in lung tissues of patients with
fibroproliferative acute respiratory distress syndrome. Am J Respir Crit
Care Med 2003, 167:83-90.
28. Negri EM, Montes GS, Saldiva PHN, Capelozzi VL: Architectural remodelling
in acute and chronic interstitial lung disease (ILD): fibrosis or
fibroelastosis? Histopathology 2000, 37:393-401.
29. Limper AH, Roman J: Fibronectin: a versatile matrix protein with roles in
thoracic development, repair and infection. Chest 1992, 101:1663-1673.
30. Bensadoun ES, Burke AK, Hogg JC, Roberts CR: Proteoglycan deposition in
pulmonary fibrosis. Am J Respir Crit Care Med 1996, 154:1819-1828.
31. Demoule A, Decailliot F, Jonson B, Christov C, Maitre B, Touqui L,
Brochard L, Delclaux C: Relationship between pressure-volume curve and
markers for collagen turn-over in early acute respiratory distress
syndrome. Intensive Care Med 2006, 32:413-420.
32. Bai A, Eidelman DH, Hogg JC, James AL, Lambert RK, Ludwig MS, Martin J,
McDonald DM, Mitzner WA, Okazawa M, Pack RJ, Paré PD, Schellenberg RR,
Tiddens HAWM, Wagner EM, Yager D: Proposed nomenclature for
quantifying subdivisions of the bronchial wall. J Appl Physiol 1994,
77:1011-1014.
33. Pugin J, Verghese G, Widmer MC, Matthay MA: The alveolar space is the
site of intense inflammatory and profibrotic reactions in the early phase
of acute respiratory distress syndrome. Crit Care Med 1999, 27:304-312.
34. Fligiel SEG, Standiford T, Fligiel HM, Tashkin D, Strieter RM, Warner RL,
Johnson KJ, Varani J: Matrix metalloproteinases and matrix
metalloproteinase inhibitors in acute lung injury. Human Pathology 2006,
37:422-430.
35. Granja C, Morujão E, Costa-Pereira A: Quality of life in acute respiratory
distress syndrome survivors may be no worst than in other ICU
survivors. Intensive Care Med 2003, 29:1744-1750.
36. Neff TA, Stocker R, Frey HR, Stein S, Russi EW: Long-term Assessment of
Lung Function in survivors of Severe ARDS. Chest 2003, 123:845-853.
37. Heyland DK, Groll D, Caeser M: Survivors of acute respiratory distress
syndrome: relationship between pulmonary dysfunction and long-term
health-related quality of life. Crit Care Med 2005, 33:1549-1553.
38. Broccard AF, Shapiro RS, Schimtz LL, Ravenscraft SA, Marini JJ: Influence of
prone position on the extent and distribution of lung injury in a high
tidal volume oleic acid model of acute respiratory distress syndrome.
Crit Care Med 1997, 25:16-27.
39. Takeuchi M, Goddon S, Dolhnikoff M, Shimaoka M, Hess D,
Amato MBP, Kacmarek RM: Set positive end-expiratory pressure
during protective ventilation affects lung injury. Anesthesiology
2002, 97:682-692.
40. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-
Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY,
Carvalho CR: Effect of a protective-ventilation strategy on mortality in
the acute respiratory distress syndrome. N Engl J Med 1998, 338:347-354.
41. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G,
Herrmann P, Mascia L, Quintel M, Slutsky AS, Gattinoni L, Ranieri VM: Tidal
Morales et al. Critical Care 2011, 15:R4
http://ccforum.com/content/15/1/R4
Page 11 of 12Hyperinflation during low tidal volume ventilation in acute respiratory
distress syndrome. Am J Respir Crit Care Med 2007, 175:160-166.
42. The Acute Respiratory Distress Syndrome Network: Ventilation with lower
tidal volumes as compared with traditional tidal volumes for acute lung
injury and the acute respiratory distress syndrome. N Engl J Med 2000,
342:1301-1308.
43. Rouby JJ, Lherm T, Martin de Lassale E, Poète P, Bodin L, Finet JF, Callard P,
Viars P: Histologic aspects of pulmonary barotrauma in critically ill
patients with acute respiratory failure. Intensive Care Med 1993,
19:383-389.
doi:10.1186/cc9401
Cite this article as: Morales et al.: Small airway remodeling in acute
respiratory distress syndrome: a study in autopsy lung tissue. Critical
Care 2011 15:R4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Morales et al. Critical Care 2011, 15:R4
http://ccforum.com/content/15/1/R4
Page 12 of 12